Transgenic expression of Helios in B lineage cells alters B cell properties and promotes lymphomagenesis

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3508-3515

  Dovat, Sinisa ^a   Montecino Rodriguez, Encarnacion ^b   Schuman, Valerie ^c   Teitell, Michael A ^b   Dorshkind, Kenneth ^b   Smale, Stephen T ^c  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN MU CHAIN; PROTEIN HELIOS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; THYMOCYTE; TRANSGENIC MOUSE;

EID: 24744471833     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3508     Document Type: Article

References (46)

1. Glimcher, L. H., and H. Singh. 1999. Transcription factors in lymphocyte development: T and B cells get together. Cell 96: 13-23.
2. Kee, B. L., and C. Murre. 2001. Transcription factor regulation of B lineage commitment. Curr. Opin. Immunol. 13: 180-185.
3. Georgopoulos, K. 2002. Haematopoietic cell-fate decisions, chromatin regulation and Ikaros. Nat. Rev. Immunol. 2: 162-174.
4. Johnson, K., and K. Calame. 2003. Transcription factors controlling the beginning and end of B-cell differentiation. Curr. Opin. Genet. Dev. 13: 522-528.
5. Busslinger, M. 2004. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22: 55-79.
6. Pui, J. C, D. Allman, L. Xu, S. DeRocco, F. G. Karnell, S. Bakkour, J. Y. Lee, T. Kadesch, R. R. Hardy, J. C. Aster, and W. S. Pear. 1999. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11: 299-308.
7. Souabni, A., C. Cobaleda, M. Schebesta, and M. Busslinger. 2002. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17: 781-793.
8. Cotta, C. V., Z. Zhang, H. G. Kim, and C. A. Klug. 2003. Pax5 determines B-versus T-cell fate and does not block early myeloid-lineage development. Blood 101: 4342-4346.
9. Zhang, Z., C. V. Cotta, R. P. Stephan, C. G. deGuzman, and C. A. Klug. 2003. Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. EMBO J. 22: 4759-4769.
10. Georgopoulos, K., D. D. Moore, and B. Derfler. 1992. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258: 808-812.
11. Cortes, M., E. Wong, J. Koipally, and K. Georgopoulos. 1999. Control of lymphocyte development by the Ikaros gene family. Curr. Opin. Immunol. 11: 167-171.
12. Morgan, B., L. Sun, N. Avitahl, K. Andrikopoulos, T. Ikeda, E. Gonzales, P. Wu, S. Neben, and K. Georgopoulos. 1997. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16: 2004-2013.
13. Hahm, K., B. S. Cobb, A. S. McCarty, K. E. Brown, C. A. Klug, R. Lee, K. Akashi, I. L. Weissman, A. G. Fisher, and S. T. Smale. 1998. Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev. 12: 782-796.
14. Kelley, C. M., T. Ikeda, J. Koipally, N. Avitahl, L. Wu, K. Georgopoulos, and B. A. Morgan. 1998. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr. Biol. 8: 508-515.
15. Honma, Y., H. Kiyosawa, T. Mori, A. Oguri, T. Nikaido, K. Kanazawa, M. Tojo, J. Takeda, Y. Tanno, S. Yokoya, et al. 1999. Eos: a novel member of the Ikaros gene family expressed predominantly in the developing nervous system. FEBS Lett. 447: 76-80.
16. Perdoma, J., M. Holmes, B. Chong, and M. Crossley. 2000. Eos and Pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. J. Biol. Chem. 275: 38347-38354.
17. Sun, L., A. Liu, and K. Georgopoulos. 1996. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15: 5358-5369.
18. McCarty, A. S., G. Kleiger, D. Eisenberg, and S. T. Smale. 2003. Selective dimerization of a C2H2 zinc finger subfamily. Mol. Cell 11: 459-470.
19. Westman, B. J., J. Perdomo, M. Sunde, M. Crossley, and J. P. Mackay. 2003. The C-terminal domain of Eos forms a high order complex in solution. J. Biol. Chem. 278: 42419-42426.
20. Hahm, K., P. Ernst, K. Lo, G. S. Kim, C. Turck, and S. T. Smale. 1994. The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol. Cell. Biol. 14: 7111-7123.
21. Molnar, A., and K. Georgopoulos. 1994. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14: 8292-8303.
22. Brown, K. E., S. S. Guest, S. T. Smale, K. Hahm, M. Merkenschlager, and A. G. Fisher. 1997. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91: 845-854.
23. Smale, S. T. 2003. The establishment and maintenance of lymphocyte identity through gene silencing. Nat. Immunol. 4: 607-615.
24. + thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 15: 1817-1832.
25. Sabbattini, P., M. Lundgren, A. Georgiou, C. Chow, G. Warnes, and N. Dillon. 2001. Binding of Ikaros to the λ5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J. 20: 2812-2822.
26. Harker, N., T. Naito, M. Cortes, A. Hostert, S. Hirschberg, M. Tolaini, K. Roderick, K. Georgopoulos, and D. Kioussis. 2002. The CD8α gene locus is regulated by the Ikaros family of proteins. Mol. Cell. 10: 1403-1415.
27. Williams, C. J., T. Naito, P. G. Arco, J. R. Seavilt, S. M. Cashman, B. De Souza, X. Qi, P. Keables, U. H. Von Andrian, and K. Georgopoulos. 2004. The chromatin remodeler Mi-2β is required for CD4 expression and T cell development. Immunity 20: 719-733.
28. Georgopoulos, K., M. Bigby, J. H. Wang, A. Molnar, P. Wu, S. Winandy, and A. Sharpe. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79: 143-156.
29. Winandy, S., P. Wu, and K. Georgopoulos. 1995. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289-299.
30. Wang, J. H., A. Nichogiannopoulou, L. Wu, L. Sun, A. H. Sharpe, M. Bigby, and K. Georgopoulos. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5: 537-549.
31. Wu, L., A. Nichogiannopoulou, K. Shortman, and K. Georgopoulos. 1997. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7: 483-492.
32. Wang, J. H., N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda, A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B. A. Morgan, and K. Georgopoulos. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity 9: 543-553.
33. Avitahl, N., S. Winandy, C. Friedrich, B. Jones, Y. Ge, and K. Georgopoulos. 1999. Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 10: 333-343.
34. Winandy, S., L. Wu, J. H. Wang, and K. Georgopoulos. 1999. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J. Exp. Med. 190: 1039-1048.
35. Kirstetter, P., M. Thomas, A. Dierich, P. Kastner, and S. Chan. 2002. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32: 720-730.
36. Papathanasiou, P., A. C. Perkins, B. S. Cobb, R. Ferrini, R. Sridharan, G. F. Hoyne, K. A. Nelms, S. T. Smale, and C. C. Goodnow. 2003. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 19: 131-144.
37. L transgene. Immunity 4: 291-299.
38. Kitamura, D., and K. Rajewsky. 1992. Targeted disruption of μ chain membrane exon causes loss of heavy chain allelic exclusion. Nature 356: 154-156.
39. Allman, D., A. Sambandam, S. Kim, J. P. Miller, A. Pagan, D. Well, A. Meraz, and A. Bhandoola. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4: 168-174.
40. Borghesi, L., L. Y. Hsu, J. P. Miller, M. Anderson, L. Herzenberg, L. Herzenberg, M. S. Schlissel, D. Allman, and R. M. Gerstein. 2004. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199: 491-502.
41. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13: 655-692.
42. Garcia de Vinuesa, C., P. O'Leary, D. M. Sze, K. M. Toellner, and I. C. MacLennan. 1999. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur. J. Immunol. 29: 1314-1323.
43. Perlmutter, R. M., D. Hansburg, D. E. Briles, R. A. Nicolotti, and J. M. Davie. 1978. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121: 566-572.
44. Takanashi, M., T. Yagi, T. Imamura, Y. Tabata, A. Morimoto, S. Hibi, E. Ishii, and S. Imashuku. 2002. Expression of the Ikaros gene family in childhood acute lymphoblastic leukemia. Br. J. Haemat. 117: 525-530.
45. Strasser, A., A. W. Harris, and S. Cory. 1993. Eμ,-Bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin- secreting cells but not T cells. Oncogens 8: 1-9.
46. Strasser, A., A. W. Harris, D. L. Vaux, E. Webb, M. L. Bath, J. M. Adams, and S. Cory. 1990. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166: 175-181.